U.S. House · 117th Congress · H.R. 6625
Equal Access to Therapeutics Act
To prohibit the Secretary of Health and Human Services from issuing guidance intended to restrict access to COVID-19 monoclonal antibody therapies and other treatments.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Rodney DavisR-IL-13
- Introduced
- February 7, 2022, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (16)
16 Republicans. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Mike BostR-IL-12
- Kat CammackR-FL-3
- Randy FeenstraR-IA-4
- Andrew R. GarbarinoR-NY-2
- Sam GravesR-MO-6
- Doug LambornR-CO-5
- Nicole MalliotakisR-NY-11
- Claudia TenneyR-NY-22
- Beth Van DuyneR-TX-24
Signed on later
- Jeff FortenberryR-NE-1February 8, 2022
- Bob GibbsR-OH-7February 8, 2022
- David B. McKinleyR-WV-1February 8, 2022
- Jefferson Van DrewR-NJ-2February 8, 2022
- Glenn GrothmanR-WI-6February 9, 2022
- Chris JacobsR-NY-27February 9, 2022
- Jason SmithR-MO-8March 17, 2022